{"title":"Breast Cancer-Related Quality of Life among Women Undergoing Treatment: A Hospital-Based Study in Vietnam.","authors":"Tuyen Dinh Hoang, Thang Van Vo, Pongdech Sarakarn","doi":"10.31557/APJCP.2026.27.9.3449","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Despite the rising incidence of breast cancer (BC), survival rates have improved due to advancements in early detection and treatment. With longer survival, it is increasingly important to evaluate and enhance patients' quality of life (QoL), particularly the functional and symptom-related aspects of BC. This study aims to assess BC-related QoL and its associated factors among women undergoing treatment.</p><p><strong>Method: </strong>A hospital-based cross-sectional study assessed BC-related QoL in 284 patients using the European Organization for Research and Treatment of Cancer (EORTC) QoL Questionnaire for BC (QLQ-BR45) between March 10 and May 14, 2025. Statistical analyses included multivariable linear regression to identify factors associated with 12 domains of patient QoL.</p><p><strong>Results: </strong>QoL findings showed high body image scores (72.51) but low sexual functioning (13.50) and sexual enjoyment (26.29), with hair-loss distress (51.32) and systemic therapy side effects (30.92) being the most burdensome symptoms. Older age and higher body mass index (BMI) had both positive and negative associations with QoL, while marriage, higher education, urban residence, and longer breastfeeding were linked to better outcomes. Late-stage disease, older age at first childbirth, and receiving no treatment were linked to poorer outcomes. Treatment had varying effects on QoL domains: surgery plus chemotherapy improved sexual enjoyment, while non-surgical approaches alleviated symptoms across several QoL-related domains.</p><p><strong>Conclusion: </strong>BC patients showed strong body image but poor sexual functioning and notable symptom burdens, underscoring the need for supportive care that addresses physical and psychosocial issues. Routine QoL monitoring and broader multicenter studies are essential to guide tailored interventions and improve overall patient QoL.</p>","PeriodicalId":55451,"journal":{"name":"Asian Pacific Journal of Cancer Prevention","volume":"27 9","pages":"3449-3456"},"PeriodicalIF":0.0000,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Pacific Journal of Cancer Prevention","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31557/APJCP.2026.27.9.3449","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Despite the rising incidence of breast cancer (BC), survival rates have improved due to advancements in early detection and treatment. With longer survival, it is increasingly important to evaluate and enhance patients' quality of life (QoL), particularly the functional and symptom-related aspects of BC. This study aims to assess BC-related QoL and its associated factors among women undergoing treatment.
Method: A hospital-based cross-sectional study assessed BC-related QoL in 284 patients using the European Organization for Research and Treatment of Cancer (EORTC) QoL Questionnaire for BC (QLQ-BR45) between March 10 and May 14, 2025. Statistical analyses included multivariable linear regression to identify factors associated with 12 domains of patient QoL.
Results: QoL findings showed high body image scores (72.51) but low sexual functioning (13.50) and sexual enjoyment (26.29), with hair-loss distress (51.32) and systemic therapy side effects (30.92) being the most burdensome symptoms. Older age and higher body mass index (BMI) had both positive and negative associations with QoL, while marriage, higher education, urban residence, and longer breastfeeding were linked to better outcomes. Late-stage disease, older age at first childbirth, and receiving no treatment were linked to poorer outcomes. Treatment had varying effects on QoL domains: surgery plus chemotherapy improved sexual enjoyment, while non-surgical approaches alleviated symptoms across several QoL-related domains.
Conclusion: BC patients showed strong body image but poor sexual functioning and notable symptom burdens, underscoring the need for supportive care that addresses physical and psychosocial issues. Routine QoL monitoring and broader multicenter studies are essential to guide tailored interventions and improve overall patient QoL.
期刊介绍:
Cancer is a very complex disease. While many aspects of carcinoge-nesis and oncogenesis are known, cancer control and prevention at the community level is however still in its infancy. Much more work needs to be done and many more steps need to be taken before effective strategies are developed. The multidisciplinary approaches and efforts to understand and control cancer in an effective and efficient manner, require highly trained scientists in all branches of the cancer sciences, from cellular and molecular aspects to patient care and palliation.
The Asia Pacific Organization for Cancer Prevention (APOCP) and its official publication, the Asia Pacific Journal of Cancer Prevention (APJCP), have served the community of cancer scientists very well and intends to continue to serve in this capacity to the best of its abilities. One of the objectives of the APOCP is to provide all relevant and current scientific information on the whole spectrum of cancer sciences. They aim to do this by providing a forum for communication and propagation of original and innovative research findings that have relevance to understanding the etiology, progression, treatment, and survival of patients, through their journal. The APJCP with its distinguished, diverse, and Asia-wide team of editors, reviewers, and readers, ensure the highest standards of research communication within the cancer sciences community across Asia as well as globally.
The APJCP publishes original research results under the following categories:
-Epidemiology, detection and screening.
-Cellular research and bio-markers.
-Identification of bio-targets and agents with novel mechanisms of action.
-Optimal clinical use of existing anti-cancer agents, including combination therapies.
-Radiation and surgery.
-Palliative care.
-Patient adherence, quality of life, satisfaction.
-Health economic evaluations.